Key Record Dates
ClinicalTrials.gov Identifier: | NCT00769470 |
---|---|
Brief Title: | Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery |
First Submitted : | October 8, 2008 |
First Submitted that Met QC Criteria : | October 8, 2008 |
First Posted : | October 9, 2008 (Estimate) |
Last Update Submitted that Met QC Criteria : | January 20, 2016 |
Last Update Posted : | January 22, 2016 (Estimate) |